Journal
CANADIAN JOURNAL OF CARDIOLOGY
Volume 25, Issue 8, Pages 469-472Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/S0828-282X(09)70119-9
Keywords
Atrial flutter; Cardiomyopathy; Implantable cardioverter defibrillator; Predictors; Tachycardiomyopathy
Categories
Ask authors/readers for more resources
BACKGROUND: There are few data oil the frequency and predictors of tachycardia-induced cardiomyopathy (TICM) in patients with persistent atrial flutter. OBJECTIVES: To examine the incidence of TICM in patients undergoing ablation for persistent atrial flutter, and to examine predictors for the development of TICM. METHODS AND RESULTS: One hundred eleven patients met the inclusion criteria for the present study. Twenty-eight of 111 (25%) patients had cardiomyopathy before ablation. Sixteen of 28 (57%) patients showed significant improvement in their left ventricular (LV) function postablation. LV function improved to normal in 12 of 16 (75%) patients. Nineteen of 28 (68%) cardiomyopathy patients had preablation LV function in the range in which they would be considered for in implantable cardioverter defibrillator for primary prevention of sudden cardiac death. In nine of 19 (47%) patients, the ejection fraction improved such that an implantable cardioverter defibrillator was no longer indicated. In multivariate analysis, average ventricular rate during atrial flutter was the only independent predictor of reversibilily of cardiomyoparhy (P=0.013). CONCLUSIONS: Sixteen of 28 (57%) cardiomyopathy patients with persistent atrial flutter had significantly improved LV function postablation. In 75% of these patients, LV function improved to normal.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available